- Home
- TSEM vs RNA Comparison
TSEM vs RNA Comparison
Compare TSEM & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSEM
- RNA
- Stock Information
- Founded
- TSEM 1993
- RNA 2012
- Country
- TSEM Israel
- RNA United States
- Employees
- TSEM N/A
- RNA N/A
- Industry
- TSEM Semiconductors
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- TSEM Technology
- RNA Health Care
- Exchange
- TSEM Nasdaq
- RNA Nasdaq
- Market Cap
- TSEM 4.0B
- RNA 3.4B
- IPO Year
- TSEM 1994
- RNA 2020
- Fundamental
- Price
- TSEM $37.50
- RNA $27.87
- Analyst Decision
- TSEM Strong Buy
- RNA Strong Buy
- Analyst Count
- TSEM 3
- RNA 12
- Target Price
- TSEM $60.00
- RNA $68.25
- AVG Volume (30 Days)
- TSEM 462.5K
- RNA 1.4M
- Earning Date
- TSEM 05-14-2025
- RNA 05-08-2025
- Dividend Yield
- TSEM N/A
- RNA N/A
- EPS Growth
- TSEM N/A
- RNA N/A
- EPS
- TSEM 1.85
- RNA N/A
- Revenue
- TSEM $1,436,122,000.00
- RNA $8,927,000.00
- Revenue This Year
- TSEM $10.99
- RNA N/A
- Revenue Next Year
- TSEM $11.17
- RNA $135.33
- P/E Ratio
- TSEM $20.26
- RNA N/A
- Revenue Growth
- TSEM 0.94
- RNA N/A
- 52 Week Low
- TSEM $28.64
- RNA $21.51
- 52 Week High
- TSEM $55.31
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- TSEM 54.98
- RNA 45.31
- Support Level
- TSEM $35.42
- RNA $25.58
- Resistance Level
- TSEM $37.65
- RNA $33.62
- Average True Range (ATR)
- TSEM 1.02
- RNA 2.09
- MACD
- TSEM 0.31
- RNA -0.29
- Stochastic Oscillator
- TSEM 74.46
- RNA 28.53
About TSEM Tower Semiconductor Ltd.
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. Tower produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. As a complement to its technology offerings, Tower offers services that enable a quick and accurate design cycle. To further assist customers with design and technical support, an integrated team helps clients through the manufacturing cycle.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.